{"id":"W2911325844","doi":"10.1093/ecco-jcc/jjy222.697","title":"P573 Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive ulcerative colitis patients: Results from the EVOLVE study","year":2019,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Paul's Hospital; Takeda (Canada); Mount Sinai Hospital","funders":"","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Infliximab; Adalimumab; Golimumab; Internal medicine; Hazard ratio; Discontinuation; Proportional hazards model; Adverse effect; Cumulative incidence; Inflammatory bowel disease; Colectomy; Confidence interval; Gastroenterology; Cohort; Tumor necrosis factor alpha; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003435781,0.0001635502,0.0006940385,0.0002978852,0.0001382544,0.0007957492,0.0002012704,0.0003495209,0.0008885514],"category_scores_gemma":[0.006128672,0.000090713,0.0008751538,0.0004732404,0.0002183996,0.000529613,0.0004242269,0.0003677261,0.000191403],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004659343,"about_ca_system_score_gemma":0.0003567429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007767658,"about_ca_topic_score_gemma":0.0009050402,"domain_scores_codex":[0.9976237,0.001272309,0.0002532244,0.0002040282,0.0005443176,0.0001023905],"domain_scores_gemma":[0.9950529,0.001803381,0.002234738,0.0002681784,0.0003629093,0.0002779698],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06453618,0.00186761,0.8260309,0.0005405365,0.002167267,0.0002392831,0.0002959238,0.001290413,0.001905121,0.0001903428,0.0006856763,0.1002508],"study_design_scores_gemma":[0.003498293,0.02248299,0.9652865,0.0001109698,0.00120452,0.0006164087,0.0003065088,0.001793659,0.001133472,0.00008637864,0.003449423,0.00003087836],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968303,0.001722553,0.0001062765,0.00005321621,0.000006271368,0.00003718131,0.0004610056,0.000004516451,0.0007787242],"genre_scores_gemma":[0.998255,0.0005319752,0.0001618428,0.00006747209,0.00002507522,0.00002351023,0.0007830319,0.000002418673,0.0001496732],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003435781,"threshold_uncertainty_score":0.01817036,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0065891235685588,"score_gpt":0.2462463610773643,"score_spread":0.2396572375088055,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}